MNOV – Medicinova Inc
Float Short %
0.26
Margin Of Safety %
Put/Call OI Ratio
0.01
EPS Next Q Diff
-0.05
EPS Last/This Y
-0.27
EPS This/Next Y
0.12
Price
1.33
Target Price
7
Analyst Recom
1
Performance Q
-4.9
Relative Volume
0.16
Beta
0.43
Ticker: MNOV
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | MNOV | 1.46 | 0.03 | 0.00 | 68 |
| 2025-07-28 | MNOV | 1.467 | 0.03 | 0.00 | 69 |
| 2025-07-29 | MNOV | 1.32 | 0.03 | 0.00 | 69 |
| 2025-07-30 | MNOV | 1.36 | 0.03 | 0.00 | 69 |
| 2025-07-31 | MNOV | 1.31 | 0.03 | 0.00 | 69 |
| 2025-08-01 | MNOV | 1.4 | 0.03 | 0.00 | 69 |
| 2025-08-04 | MNOV | 1.35 | 0.03 | 0.00 | 69 |
| 2025-08-05 | MNOV | 1.37 | 0.02 | 0.00 | 118 |
| 2025-08-06 | MNOV | 1.3507 | 0.01 | 0.00 | 167 |
| 2025-08-07 | MNOV | 1.35 | 0.01 | 0.00 | 167 |
| 2025-08-08 | MNOV | 1.34 | 0.01 | 0.00 | 167 |
| 2025-08-11 | MNOV | 1.3393 | 0.01 | 0.00 | 198 |
| 2025-08-12 | MNOV | 1.31 | 0.01 | 0.00 | 198 |
| 2025-08-13 | MNOV | 1.2793 | 0.01 | 0.00 | 198 |
| 2025-08-14 | MNOV | 1.2897 | 0.01 | 0.00 | 198 |
| 2025-08-15 | MNOV | 1.33 | 0.01 | 0.00 | 223 |
| 2025-08-18 | MNOV | 1.315 | 0.01 | 0.00 | 258 |
| 2025-08-19 | MNOV | 1.305 | 0.01 | 0.00 | 335 |
| 2025-08-20 | MNOV | 1.32 | 0.01 | 0.00 | 335 |
| 2025-08-21 | MNOV | 1.3 | 0.01 | 0.00 | 335 |
| 2025-08-22 | MNOV | 1.32 | 0.01 | 0.00 | 335 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | MNOV | 1.46 | - | - | -0.50 |
| 2025-07-28 | MNOV | 1.48 | - | - | -0.50 |
| 2025-07-29 | MNOV | 1.33 | - | - | -0.50 |
| 2025-07-30 | MNOV | 1.35 | - | - | -0.50 |
| 2025-07-31 | MNOV | 1.33 | - | - | -0.50 |
| 2025-08-01 | MNOV | 1.43 | - | - | -0.50 |
| 2025-08-04 | MNOV | 1.35 | - | - | -0.50 |
| 2025-08-05 | MNOV | 1.36 | - | - | -0.50 |
| 2025-08-06 | MNOV | 1.36 | - | - | -0.50 |
| 2025-08-07 | MNOV | 1.37 | - | - | -0.50 |
| 2025-08-08 | MNOV | 1.35 | - | - | -0.50 |
| 2025-08-11 | MNOV | 1.34 | - | - | -0.50 |
| 2025-08-12 | MNOV | 1.30 | - | - | -0.50 |
| 2025-08-13 | MNOV | 1.27 | - | - | -0.50 |
| 2025-08-14 | MNOV | 1.29 | - | - | -0.50 |
| 2025-08-15 | MNOV | 1.33 | - | - | -0.50 |
| 2025-08-18 | MNOV | 1.31 | - | - | -0.50 |
| 2025-08-19 | MNOV | 1.30 | - | - | -0.50 |
| 2025-08-20 | MNOV | 1.32 | - | - | -0.50 |
| 2025-08-21 | MNOV | 1.30 | - | - | -0.50 |
| 2025-08-22 | MNOV | 1.33 | - | - | -0.50 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | MNOV | 0.00 | -0.55 | 0.27 |
| 2025-07-28 | MNOV | 0.00 | -0.55 | 0.27 |
| 2025-07-29 | MNOV | 0.00 | -0.55 | 0.27 |
| 2025-07-30 | MNOV | 0.00 | -0.55 | 0.27 |
| 2025-07-31 | MNOV | 0.00 | -0.55 | 0.27 |
| 2025-08-01 | MNOV | 0.00 | -0.55 | 0.27 |
| 2025-08-04 | MNOV | 0.00 | -0.55 | 0.27 |
| 2025-08-05 | MNOV | 0.00 | -0.55 | 0.27 |
| 2025-08-06 | MNOV | 0.00 | -0.55 | 0.27 |
| 2025-08-07 | MNOV | 0.00 | -0.55 | 0.27 |
| 2025-08-08 | MNOV | 0.00 | -0.55 | 0.27 |
| 2025-08-11 | MNOV | 0.00 | -0.55 | 0.27 |
| 2025-08-12 | MNOV | 0.00 | -0.55 | 0.26 |
| 2025-08-13 | MNOV | 0.00 | -0.55 | 0.26 |
| 2025-08-14 | MNOV | 0.00 | -0.55 | 0.26 |
| 2025-08-15 | MNOV | 0.00 | -0.55 | 0.26 |
| 2025-08-18 | MNOV | 0.00 | -1.48 | 0.26 |
| 2025-08-19 | MNOV | 0.00 | -1.48 | 0.26 |
| 2025-08-20 | MNOV | 0.00 | -1.48 | 0.26 |
| 2025-08-21 | MNOV | 0.00 | -1.48 | 0.26 |
| 2025-08-22 | MNOV | 0.00 | -1.48 | 0.26 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.07
Avg. EPS Est. Current Quarter
-0.12
Avg. EPS Est. Next Quarter
-0.12
Insider Transactions
Institutional Transactions
-1.48
Beta
0.43
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
22
Growth Score
24
Sentiment Score
61
Actual DrawDown %
87.7
Max Drawdown 5-Year %
-87.1
Target Price
7
P/E
Forward P/E
PEG
P/S
495.14
P/B
1.37
P/Free Cash Flow
EPS
-0.24
Average EPS Est. Cur. Y
-0.5
EPS Next Y. (Est.)
-0.38
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-8775.8
Relative Volume
0.16
Return on Equity vs Sector %
-49.9
Return on Equity vs Industry %
-37
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
MediciNova, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 13
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. It is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. The company has a license agreement with Kyorin Pharmaceuticals for the development and commercialization of MN-166 and MN-001. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
stock quote shares MNOV – Medicinova Inc Stock Price stock today
news today MNOV – Medicinova Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MNOV – Medicinova Inc yahoo finance google finance
stock history MNOV – Medicinova Inc invest stock market
stock prices MNOV premarket after hours
ticker MNOV fair value insiders trading